Science & Enterprise subscription

Follow us on Twitter

  • Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were high… https://t.co/oLdLmHGz1M
    about 9 hours ago
  • New post on Science and Enterprise: Venture Funds, Mergers in A.I. Up Sharply in 2018 https://t.co/rimak87tjS #Science #Business
    about 9 hours ago
  • Wish it weren't needed, but ... https://t.co/SZAb2GO2vz
    about 3 days ago
  • The Edelman public relations agency released results of a survey earlier this month gauging the public's awareness… https://t.co/XaxxGJOYQl
    about 3 days ago
  • New post on Science and Enterprise: Infographic – Public, Tech Execs Differ on A.I. Use https://t.co/cvVj3IyCR0 #Science #Business
    about 3 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Venture Funds, Mergers in A.I. Up Sharply in 2018

Glasses, computer screens

Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were highly prized acquisition targets in 2018, a new analysis shows. . . . → Read More: Venture Funds, Mergers in A.I. Up Sharply in 2018

Biogen Acquires Gene Therapy Company in $800M Deal

Eye exam

A company developing treatments for inherited eye diseases that replace malfunctioning with healthy genes is being acquired by biotechnology company Biogen. . . . → Read More: Biogen Acquires Gene Therapy Company in $800M Deal

Gene Therapy Company Acquired in $4.3B Deal

Retinal gene therapy

Spark Therapeutics, a biotechnology company that pioneered gene therapies, is being acquired by drug maker Roche Group in a deal valued at $4.3 billion. . . . → Read More: Gene Therapy Company Acquired in $4.3B Deal

Start-Up Raises $10.5M for Precision Immunotherapies

Business newspaper

A new biotechnology enterprise developing personalized treatments that harness the immune system to treat cancer is raising $10.5 million in its first venture funding round. . . . → Read More: Start-Up Raises $10.5M for Precision Immunotherapies

Company to Stop Cancer Spread, Relapse Raises $60.8M

Cancer magnified

A new company formed to commercialize research that aims to prevent cancer from spreading or recurring is raising $60.75 million in its first venture financing. . . . → Read More: Company to Stop Cancer Spread, Relapse Raises $60.8M

Venture Fund Formed to Back Longevity Research

Older hands on keyboard

A new venture capital fund is being formed to finance start-up companies developing technologies that aim to extend healthy human life spans. . . . → Read More: Venture Fund Formed to Back Longevity Research

Infographic – Apple Phone Sales Down, Wearables Up

Apple earnings Q1 2019

Apple makes more than phones, and while the volume of sales in these other company units is smaller, the percentage gains from last year are healthy. . . . → Read More: Infographic – Apple Phone Sales Down, Wearables Up

Expanding Gel Pill Designed for Long-Term Diagnostics

Expanding ingestible get

An ingestible gel capsule is shown in tests with animals to expand and reside in the stomach for as long as a month for delivering drugs or monitoring bodily functions. . . . → Read More: Expanding Gel Pill Designed for Long-Term Diagnostics

Start-Ups Saying No Thanks to Venture Capital

Calculator cash calendar

Yesterday, we reported on 2018 being a banner year for venture capital, but the New York Times says a movement of entrepreneurs is looking for other ways to raise money. . . . → Read More: Start-Ups Saying No Thanks to Venture Capital

Infographic – Venture Finance Reaching Dot-Com Levels

Venture capital by year

Venture funding last year totaled $99.5 billion, the largest annual outlay since 2000. . . . → Read More: Infographic – Venture Finance Reaching Dot-Com Levels